OWL Metabolomics

• Disponible sur:
• English
• Français

OWL is a leading biotechnology company engaged in identifying biomarkers and therapeutic targets for high prevalent diseases. The company predominantly caters to the human health industry and is renowned for its pioneering applications in the international scientific community. OWL's primary mission is to identify, validate, patent and commercialize cutting-edge diagnosis and prognosis systems, coupled with therapeutic targets. The company's expertise lies in developing innovative solutions for serious health conditions, including oncology, infectious diseases, and neurodegenerative disorders. OWL's state-of-the-art facilities and team of highly skilled professionals position the company at the forefront of the biotechnology industry.